Short contact therapy of acne with tretinoin

References

• Kang S. The mechanism of action of topical retinoids. Cutis. 2005;75:10–13.
   PubMed Web of Science ®Google Scholar
• Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19:272–279.
   PubMed Web of Science ®Google Scholar
• Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol. 2005;4:41–47.
   PubMedGoogle Scholar
• Richter JR, Förström LR, Kiistala UO, Jung EG. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. JEADV. 1998;11:227–233.
   Google Scholar
• Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double- blind, controlled study. J Am Acad Dermatol. 2007;57:791–799.
   PubMed Web of Science ®Google Scholar
• Lavker RM, Leyden JJ, Thorne EG. An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther. 1992;14:773–780.
   PubMedGoogle Scholar
• Jones DA. The potential immunomodulatory effects of topical retinoids. Dermatol Online J. 2005;11:3.
   PubMedGoogle Scholar
• Vega-Diaz B, Jonard A, Michel S. Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene. JEADV. 2002;16:123–124.
   Google Scholar
• Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol. 2002;22:4522–4534.
   PubMedGoogle Scholar
• Simoni D, Tolomeo M. Retinoids, apoptosis and cancer. Curr Pharm Des. 2001;7:1823–1837.
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ. Acne. Martin Dunitz, London: 1994. pp 242.
   Google Scholar
• Heel RC, Brogden RN, Speight TM, Avery GS. Vitamin A acid: a review of its pharmacological properties and therapeutic use in the topical treatment of acne vulgaris. Drugs. 1977;14:401–419.
   PubMedGoogle Scholar
• Veraldi S, Schianchi R. Short contact therapy of acne with tretinoin. Eur J Acne. 2011;2:1–2.
   Google Scholar
• Cunliffe WJ, Gollnick HPM. Acne. Diagnosis and management. Martin Dunitz, London: 2001. pp 110.
   Google Scholar
• Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, et al. Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol. 1994;103:770–774.
   PubMed Web of Science ®Google Scholar
• Jordan WP Jr, Higgins M, Dvorak J. Allergic contact dermatitis to All-trans-retinoic acid; epicutaneous and leukocyte migration inhibition testing. Contact Dermatitis. 1975;1:306–310.
   PubMedGoogle Scholar
• Slade HB, Shroot B, Feldman SR, Cargill DI, Stanfield J. Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. Photodermatol Photoimmunol Photomed. 2009;25:146–152.
   PubMedGoogle Scholar
• Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416–418.
   PubMed Web of Science ®Google Scholar
• Phillips TJ. An update on the safety and efficacy of topical retinoids. Cutis. 2005;75:14–24.
   PubMed Web of Science ®Google Scholar
• Domínguez J, Hojyo MT, Celayo JL, Domínguez-Soto L, Teixeira F. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol. 1998;37:54–55.
   PubMedGoogle Scholar
• Chalker DK, Lesher JL Jr, Smith JG Jr, Klauda HC, Pochi PE, Jacoby WS, et al. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J Am Acad Dermatol. 1987;17:251–254.
   PubMedGoogle Scholar
• Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs. 2004;64:1465–1478.
   PubMed Web of Science ®Google Scholar
• Veraldi S, Schianchi R. Short-contact therapy with tazarotene in psoriasis vulgaris. Dermatology. 2003;206:347.
   PubMed Web of Science ®Google Scholar
• Veraldi S, Caputo R, Pacifico A, Peris K, Soda R, Chimenti S. Short-contact therapy with tazarotene in psoriasis vulgaris. Dermatology. 2006;212:235–237.
   PubMed Web of Science ®Google Scholar
• Paquette D, Badiavas E, Falanga V. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds. J Am Acad Dermatol. 2001;45:382–386.
   PubMed Web of Science ®Google Scholar
• Tom WL, Peng DH, Allaei A, Hsu D, Hata TR. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Arch Dermatol. 2005;141:1373–1377.
   PubMedGoogle Scholar
• Bershad S. Developments in topical retinoid therapy for acne. Sem Cutan Med Surg. 2001;20:154–161.
   PubMed Web of Science ®Google Scholar
• Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, et al. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002;138:481–489.
   PubMed Web of Science ®Google Scholar
• Lehmann PA, Malany AM. Evidence for percutaneous absorption of isotretinoin from the photoisomerization of topical tretinoin. J Invest Dermatol. 1989;93:595–599.
   PubMedGoogle Scholar
• Lehmann PA, Slattery JT, Franz TJ. Percutaneous absorption of retinoids: Influence of vehicle, light exposure, and dose. J Invest Dermatol. 1988;91:56–61.
   PubMedGoogle Scholar
• Schaefer H. Penetration and percutaneous absorption of topical retinoids. Skin Pharmacol. 1993;6:17–23.
   PubMedGoogle Scholar
• Tavakkol A, Zouboulis CC, Duell EA, Voorhees JJ. A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro. Mol Biol Rep. 1994;20:75–83.
   PubMed Web of Science ®Google Scholar
• Roos TC, Jugert FK, Merk HF, Bickers DR. Retinoid metabolism in the skin. Pharmacol Rev. 1998;50:315–333.
   PubMed Web of Science ®Google Scholar